Precision Dosing: The Clinical Pharmacology of Goldilocks
- PMID: 33616906
- DOI: 10.1002/cpt.2112
Precision Dosing: The Clinical Pharmacology of Goldilocks
Similar articles
-
Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine.Clin Pharmacol Ther. 2024 Sep;116(3):491-496. doi: 10.1002/cpt.3375. Clin Pharmacol Ther. 2024. PMID: 39164848 No abstract available.
-
Precision dosing in clinical medicine: present and future.Expert Rev Clin Pharmacol. 2018 Aug;11(8):743-746. doi: 10.1080/17512433.2018.1501271. Epub 2018 Jul 20. Expert Rev Clin Pharmacol. 2018. PMID: 30010447 No abstract available.
-
Model-Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing.Clin Pharmacol Ther. 2020 Apr;107(4):853-857. doi: 10.1002/cpt.1777. Epub 2020 Feb 23. Clin Pharmacol Ther. 2020. PMID: 31955414 Review.
-
Supporting Precision Dosing in Drug Labeling.Clin Pharmacol Ther. 2021 Jan;109(1):37-41. doi: 10.1002/cpt.2054. Epub 2020 Oct 27. Clin Pharmacol Ther. 2021. PMID: 33111328 Review. No abstract available.
-
Precision Dosing: An Industry Perspective.Clin Pharmacol Ther. 2021 Jan;109(1):47-50. doi: 10.1002/cpt.2064. Epub 2020 Oct 26. Clin Pharmacol Ther. 2021. PMID: 33107023 Free PMC article. Review. No abstract available.
Cited by
-
Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research.Expert Opin Drug Metab Toxicol. 2023 Jan;19(1):1-11. doi: 10.1080/17425255.2023.2178897. Epub 2023 Feb 18. Expert Opin Drug Metab Toxicol. 2023. PMID: 36800927 Free PMC article. Review.
-
Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity.Front Immunol. 2025 Jan 30;15:1527961. doi: 10.3389/fimmu.2024.1527961. eCollection 2024. Front Immunol. 2025. PMID: 39949718 Free PMC article.
-
Precision antiplatelet therapy.Res Pract Thromb Haemost. 2023 Mar 28;7(3):100138. doi: 10.1016/j.rpth.2023.100138. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37215094 Free PMC article.
References
-
- Stout, S.M. et al. Interpretation of cytochrome P‐450 inhibition and induction effects from clinical data: current standards and recommendations for implementation. Clin. Pharmacol. Ther. 109, 82–86 (2021).
-
- Yang, X., Pfuma Fletcher, E., Huang, S.M., Zineh, I. & Madabushi, R. Regulatory efforts to facilitate evaluation and clinical management of drug‐drug interaction risks. Clin. Pharmacol. Ther. 109, 42–46 (2021).
-
- Achour, B. et al. Liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters. Clin. Pharmacol. Ther. 109, 222–232 (2021).
-
- Zamek‐Gliszczynski, M.J. et al. Intestinal P‐gp and putative hepatic OATP1B induction: international transporter consortium perspective on drug development implications. Clin. Pharmacol. Ther. 109, 55–64 (2021).
-
- Liu, M. et al. A tutorial for pharmacogenomics implementation through end‐to‐end clinical decision support based on ten years of experience from PREDICT. Clin. Pharmacol. Ther. 109, 101–115 (2021).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical